loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of GW282974X Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 2,937Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Naprod Life Sciences

02 1Accure Labs

03 1Jodas Expoim Pvt. Ltd

04 1Natco Pharma

05 2Novartis Pharmaceuticals Australia Pty Limited

06 3Novartis Pharmaceuticals Corporation

07 1Novartis South Africa (Pty) Ltd

08 1Teva Pharmaceutical Industries

09 1TherDose Pharma

10 4Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Lapatinib Ditosylate

Brand Name :

Dosage Form : Tablets

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2020-09-29

Application Number : 203007

Regulatory Info : RX

Registration Country : USA

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : TYKERB

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2007-03-13

Application Number : 22059

Regulatory Info : RX

Registration Country : USA

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Lapatinibum

Brand Name : Tyverb

Dosage Form : Tabs

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Lapatinibum

Brand Name : Tyverb

Dosage Form : Tabs

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2024-08-16

Application Number : 217968

Regulatory Info : RX

Registration Country : USA

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Lapatinib Ditosylate

Brand Name : LAPATITHER

Dosage Form : Tablets

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

10

Country
Discovery on Target
Not Confirmed
arrow

Country
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Lapatinib 250Mg 70 Units' Oral Use

Dosage Strength : 70 cpr riv 250 mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

Country
Discovery on Target
Not Confirmed
arrow

Country
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Lapatinib 250Mg 84 Combined Oral Use

Dosage Strength : 84 cpr riv 250 mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

12

Country
Discovery on Target
Not Confirmed
arrow

Country
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Antic-calc Tablet

Dosage Strength : 250 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

Country
Discovery on Target
Not Confirmed
arrow

Country
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Antic-calc Tablet

Dosage Strength : 250 mg

Packaging : Box of plastic

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

Novartis South Africa (Pty) Ltd

Country
Discovery on Target
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
Discovery on Target
Not Confirmed

Lapatinib

Brand Name : Tykerb

Dosage Form : FCT

Dosage Strength : 250mg

Packaging : 70X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

15

Novartis Pharmaceuticals Australia ...

Country
Discovery on Target
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Discovery on Target
Not Confirmed

lapatinib

Brand Name : Tykerb

Dosage Form :

Dosage Strength :

Packaging : 70

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

Novartis Pharmaceuticals Australia ...

Country
Discovery on Target
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Discovery on Target
Not Confirmed

lapatinib

Brand Name : Tykerb

Dosage Form :

Dosage Strength :

Packaging : 70

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank